Daxing Biotech Firm Achieves Breakthrough Stroke Treatment Innovation

Since its founding, Allife Medicine, a biomedical tech company in Beijing Daxing Economic Development Zone, has secured over 100 patents.

Their breakthrough ALF201, the world's first iEPC drug, fills a gap in stroke treatment by extending the "golden treatment window" to 7 days, significantly reducing disability and mortality rates. 

This marks a milestone for Daxing in advancing its biomedical industry!